KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ)
$4.18 0.03 (0.7229%)
Analysed KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) News Sources
KORU Medical Systems, Inc. Q4 2025 Earnings Call Summary
13-03-2026
moby.co
KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump
17-03-2026
yahoo.com
Phreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar?
20-03-2026
yahoo.com
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
16-04-2026
yahoo.com
We Think KORU Medical Systems (NASDAQ:KRMD) Can Easily Afford To Drive Business Growth
01-05-2026
yahoo.com
KORU Medical Systems Announces First Quarter 2026 Results
06-05-2026
yahoo.com
KORU Medical Systems Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
KORU Medical Systems, Inc. Q1 2026 Earnings Call Summary
07-05-2026
moby.co
May 2026 Penny Stocks Worth Watching
08-05-2026
yahoo.com
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
18-05-2026
yahoo.com
What is the current price of KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ)?
The current price of KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) is $4.18.
KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) since the previous trading day is $0.03.
KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) since the previous trading day is 0.7229%.
What is the most recent average sentiment score for KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ)?
The most recent average sentiment score for KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ)?
The most recent sentiment for KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ) is .
SEC-8K** Filing Available For KORU MEDICAL SYSTEMS INC (KRMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.